Trial intelligence / Profile preview

Ferrlecit vs Oral Iron in Peritoneal Dialysis Patients

NCT00223977Phase 3Completed

Sponsor
Watson Pharmaceuticals
Start
Dec 2003
Primary completion
Nov 2004
Modality
Small Molecules
Countries
8
01

Overview

A Phase 3 trial of sodium ferric gluconate in iron deficiency anemia (IDA), sponsored by Watson Pharmaceuticals. Started Dec 2003; status: completed.

02

Drugs

sodium ferric gluconate
03

Conditions

iron deficiency anemia (IDA)

Beyond the preview

Go deeper on NCT00223977.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00223977.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call